Prostate Cancer - Results from #21320

Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium - Abstract February 7, 2014

Quantifying the combined effect of radiation therapy and hyperthermia in terms of equivalent dose distributions - Abstract February 7, 2014

The impact of gastrointestinal and genitourinary toxicity on health related quality of life among irradiated prostate cancer patients - Abstract February 7, 2014

A feasible and time-efficient adaptation of NeuroSAFE for da Vinci robot-assisted radical prostatectomy - Abstract February 7, 2014

Receipt of guideline-concordant treatment in elderly prostate cancer patients - Abstract February 7, 2014

Beyond sipuleucel-T: Immune approaches to treating prostate cancer - Abstract February 7, 2014

Latent hypothyreosis as a clinical biomarker for therapy response under abiraterone acetate therapy - Abstract February 6, 2014

Pain and analgesic usage after robotic assisted radical prostatectomy - Abstract February 6, 2014

Combined brachytherapy and external beam radiotherapy without adjuvant androgen deprivation therapy for high-risk prostate cancer - Abstract February 6, 2014

Vitamin D and prostate cancer survival in veterans - Abstract February 6, 2014

Downgrading of biopsy based Gleason score in prostatectomy specimens - Abstract February 6, 2014

Sensorimotor polyneuropathy and foot-drop as result of a prostate cancer paraneoplastic syndrome - Abstract February 6, 2014

(11)C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy - Abstract February 6, 2014

A pilot study of potential pre-operative barriers to couples' sexual recovery after radical prostatectomy for prostate cancer - Abstract February 6, 2014

Prognostic impact of young age on stage IV prostate cancer treated with primary androgen deprivation therapy - Abstract February 6, 2014

Cumulative risk of developing prostate cancer in men with low (≤ 2.0 ng/mL) prostate-specific antigen levels: A population-based screening cohort study in Japan - Abstract February 6, 2014

Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: A modelling study from a health care perspective - Abstract February 6, 2014

Potential usefulness of CTC detection in follow up of prostate cancer patients. A preliminary report obtained by using Adnagene platform - Abstract February 6, 2014

Modified radical retropubic prostatectomy: Personal technical variation "tension free continuum-urethral anastomosis (T.F.C.U.A)" with optical magnification in the preservation of the bladder neck, and estimation of the urinary continence - Abstract February 6, 2014

Prostate-specific antigen screening: A critical review of current research and guidelines - Abstract February 6, 2014

Page 1067 of 1438